Funded Health Care Startups in Zürich
Disclosed funding in this Zürich health care slice is skewed by one clear outlier: SkyCell’s $59M round on 2024-06-25 is the only disclosed amount above $5…
Disclosed funding in this Zürich health care slice is skewed by one clear outlier: SkyCell’s $59M round on 2024-06-25 is the only disclosed amount above $50M; the next-largest disclosed rounds are $21M and below (Nanoleq’s $13M on 2021-12-16, Somagenetix’s $12M on 2024-10-08, and Simulands’ $11M on 2023-03-02). A second pattern is temporal clustering: five of the 17 rows (29%) fall between 2024-06-25 and 2025-06-10, including entries on 2025-06-10 (Positrigo, $9M), 2025-02-07 (Scanvio, $160K), 2024-06-28 (Circleg, $2M), and 2024-06-25 (SkyCell, $59M). Geographic concentration is tight: all 17 entries list Zürich/Zurich, with every row except one explicitly matching “Zürich, Zurich, Switzerland.” The stage/amount mix also shows breadth, with Series Unknown appearing in 5 rows (Positrigo 2025-06-10, Scanvio 2025-02-07, Resmonics 2025-01-16, Circleg 2024-06-28, and derma2go 2022-12-15) and undisclosed amounts in 2 rows (CustomSurg 2024-03-19 and Aepsy 2022-10-26). Rounds span 2020-07-23 (MyoSwiss, $2M) through 2025-06-10 (Positrigo, $9M).
Most recent rounds
17 shownRelated listings
Frequently asked
What stands out on deal size in this Zürich health care list, and how does the top round compare to the rest?
SkyCell’s $59M (2024-06-25) is the only disclosed round above $50M, and it dwarfs the next-largest disclosed amounts (e.g., Nanoleq $13M on 2021-12-16 and Somagenetix $12M on 2024-10-08). Several other disclosed rounds are clustered around single-digit millions, such as Akina $2M (2022-11-01) and Pipra $2M (2022-06-16).
Are funding events concentrated in a specific recent time window?
Yes: five of 17 rows fall between 2024-06-25 and 2025-06-10, including SkyCell $59M (2024-06-25), Circleg $2M (2024-06-28), Somagenetix $12M (2024-10-08), Resmonics $210K (2025-01-16), and Positrigo $9M (2025-06-10). The most recent entry in the table is Positrigo on 2025-06-10.
How concentrated is the geography within the Zürich label?
All 17 entries are tied to Zürich/Zurich. Every row except Akina uses “Zürich, Zurich, Switzerland,” and Akina is listed as “Zurich, Switzerland,” suggesting a single-city clustering rather than multiple metro splits.
What stage mix dominates, and how much is missing classification or amount?
Series Unknown appears in 5 of 17 rows (Positrigo 2025-06-10, Scanvio 2025-02-07, Resmonics 2025-01-16, Circleg 2024-06-28, derma2go 2022-12-15). Two additional rows have undisclosed amounts (CustomSurg 2024-03-19 and Aepsy 2022-10-26), while disclosed amounts range from $160K (Scanvio, 2025-02-07) up to $59M (SkyCell, 2024-06-25).
Which entry looks most like a low-end outlier by disclosed amount?
Scanvio at $160K (2025-02-07) is the smallest disclosed amount in the table, sitting far below other low disclosed figures like Resmonics $210K (2025-01-16) and Nanoleq’s $13M (2021-12-16). Because two companies are marked undisclosed (CustomSurg and Aepsy), comparisons should focus on disclosed amounts only.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.